Fluorinated Polymer Nanoparticles as a Novel 19F MRI Contrast Agent Prepared by Dendrimer-Initiated Living Radical Polymerization

2010 ◽  
Vol 211 (12) ◽  
pp. 1369-1376 ◽  
Author(s):  
Michihiro Ogawa ◽  
Satoshi Nitahara ◽  
Hiroyuki Aoki ◽  
Shinzaburo Ito ◽  
Michiko Narazaki ◽  
...  
2012 ◽  
Vol 85 (1) ◽  
pp. 79-86 ◽  
Author(s):  
Michihiro Ogawa ◽  
Hiromasa Kataoka ◽  
Satoshi Nitahara ◽  
Hiroyuki Fujimoto ◽  
Hiroyuki Aoki ◽  
...  

RSC Advances ◽  
2015 ◽  
Vol 5 (105) ◽  
pp. 86779-86783 ◽  
Author(s):  
M. Borges ◽  
S. Yu ◽  
A. Laromaine ◽  
A. Roig ◽  
S. Suárez-García ◽  
...  

A novel dual T1/T21H-MRI contrast agent based on the encapsulation of super-paramagnetic iron oxide nanoparticles (SPIONs) with an iron coordination polymer is proposed.


2010 ◽  
Vol 211 (14) ◽  
pp. 1602-1609 ◽  
Author(s):  
Michihiro Ogawa ◽  
Satoshi Nitahara ◽  
Hiroyuki Aoki ◽  
Shinzaburo Ito ◽  
Michiko Narazaki ◽  
...  

RSC Advances ◽  
2019 ◽  
Vol 9 (25) ◽  
pp. 14051-14059
Author(s):  
Abdulrahman Ahmed Mahmood ◽  
Jianqi Zhang ◽  
Rufang Liao ◽  
Xiwei Pan ◽  
Dan Xu ◽  
...  

The acid-responsive pHLIP modified SPION as an MRI contrast agent for liver cancer diagnosis requires the validation of both the tumor-specific enhancement and a safe profile in cirrhosis.


Author(s):  
N. Riyahi-Alam ◽  
J. Behrouzkia ◽  
S. Haghgoo ◽  
A Seifalian ◽  
R Zohdi Aghdam. ◽  
...  

Nanomaterials ◽  
2021 ◽  
Vol 11 (5) ◽  
pp. 1235
Author(s):  
Xiaohui Nan ◽  
Wenjia Lai ◽  
Dan Li ◽  
Jiesheng Tian ◽  
Zhiyuan Hu ◽  
...  

Derived from magnetotactic bacteria (MTB), magnetosomes consist of magnetite crystals enclosed within a lipid bilayer membrane and are known to possess advantages over artificially synthesized nanoparticles because of the narrow size distribution, uniform morphology, high purity and crystallinity, single magnetic domain, good biocompatibility, and easy surface modification. These unique properties have increasingly attracted researchers to apply bacterial magnetosomes (BMs) in the fields of biology and medicine as MRI imaging contrast agents. Due to the concern of biosafety, a long-term follow-up of the distribution and clearance of BMs after entering the body is necessary. In this study, we tracked changes of BMs in major organs of mice up to 135 days after intravenous injection using a combination of several techniques. We not only confirmed the liver as the well-known targeted organs of BMs, but also found that BMs accumulated in the spleen. Besides, two major elimination paths, as well as the approximate length of time for BMs to be cleared from the mice, were revealed. Together, the results not only confirm that BMs have high biocompatibility, but also provide a long-term in-vivo assessment which may further help to forward the clinical applications of BMs as an MRI contrast agent.


Author(s):  
Juliette Moreau ◽  
Maité Callewaert ◽  
Volodymyr Malytskyi ◽  
Céline Henoumont ◽  
Sorina N. Voicu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document